DOI: 10.25881/BPNMSC.2018.49.83.014

Authors

Kulko A.B.1, Fedorova N.I.2

1. Moscow Municipal Scientific and Practical Center for Tuberculosis Control of the Department of Health of Moscow, Moscow.

2. Federal State Public Institution «National Medical and Surgical Center named after N.I. Pirogov» of the Ministry of Healthcare of the Russian Federation.

Abstract

We evaluated and analyzed levels of susceptibility to modern antifungals for 12 causative agents of aspergillosis: Aspergillus flavipes, A. flavus, A. fumigatus, A. glaucus, A. nidulans, A. niger, A. ochraceus, A. oryzae, A. sydowii, A. terreus, A. ustus, A. versicolor. Determination of antimycotic susceptibility of 217 clinical strains of Aspergillus spp. carried out by the broth microdilution method with determination of MIC (μg/ml) (the «Sensititre» system). We established that causative agents of aspergillosis differed by levels of susceptibility to amphotericin B. We also observed high activity of voriconazole, itraconazole, and posaconazole against Aspergillus spp., except some strains of A. ustus (reduced susceptibility to azoles, testing before treatment is required), and several strains of A. nidulans and A. niger.

Keywords: pulmonary aspergillosis; susceptibility of fungi from genus Aspergillus to antimycotics; the «Sensititre» test system.

References

1. Diagnostika i lechenie mikozov. Pod red. D. R. Hospentala, M. Dzh. Rinaldi (D.R. Hospenthal, M.G. Rinaldi.) Per. s angl. pod red. YU.V.Sergeeva. – M.: GEHOTAR-Media. – 2013. – 448 s.

2. Diagnostika i lechenie mikozov v otdeleniyah reanimacii i intensivnoj terapii: Rossijskie rekomendacii /Otv. red. N.N. Klimko. – 2-e izd., dop. i pererab. – M.: Farmtek, 2015. – 96 s.

3. Klimko N.N. Mikozy: diagnostika i lechenie. Rukovodstvo dlya vrachej. 2-e izd. pererab. i dop. – M.: Vi Dzhi Grupp, 2008. – 336 s.

4. Kul'ko A. B. Atlas uslovno-patogennyh gribov roda Aspergillus – vozbuditelej bronholegochnyh infekcij. – M.: MNPCBT. – 2012. – 160 s.

5. Kul'ko A.B. Laboratornaya diagnostika legochnogo aspergilleza u bol'nyh tuberkulezom organov dyhaniya: algoritm issledovanij i kriterii interpretacii poluchaemyh rezul'tatov // Tuberkulez i social'no znachimye zabolevaniya. – 2016. – № 2. – S. 49-53.

6. Kul'ko A.B., Dreval' P.A., Vorob'ev A.A., Trusov V.N. Laboratornaya diagnostika bronholegochnogo aspergilleza u bol'nyh tuberkulezom s polostnymi obrazovaniyami v legkih // Problemy medicinskoj mikologii. – 2008. – T.10. №4. – S. 25-28.

7. Maschan A.A., Klyasova G.A., Veselov A.V. Obzor rekomendacij amerikanskogo obshchestva po infekcionnym boleznyam po lecheniyu aspergilleza // Klinicheskaya mikrobiologiya i antimikrobnaya himioterapiya. – 2008. – T. 10. № 2. – S. 96–143.

8. Mitrofanov V.S., Svirshchevskaya E.V. Aspergillez legkih. 2-e izd., pererab. i dop. – SPb.: Izdatel'stvo Foliant. – 2013. – 184 s.

9. Satton D., Fotergill A., Rinal'di M. (Sutton D., Fothergill A., Rinaldi M.) Opredelitel' patogennyh i uslovno patogennyh gribov: Per. s angl. – M.: Izdatel'stvo Mir. – 2001. – 468 s.

10. Sergeev A.YU., Sergeev YU.V. Gribkovye infekcii. Rukovodstvo dlya vrachej. – M.: Izd-vo Binom, 2008. – 480 s.

11. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard – Second edition. SLCI document M38-A2. CLSI: Wayne, PA., 2008. – 40 p.

12. Denning D.W., Pleuvry A., Cole D.C. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis // Bull World Health Organ. – 2011. – Vol. 1, №89(12). – P. 864-872.

13. EUCAST Definitive Document E.DEF 9.1: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST), 2008 – 13 p.

14. European Committee on Antimicrobial Susceptibility Testing. Antifungal Agents Breakpoint tables for interpretation of MICs. Version 8.0, valid from 2015-11-16, 2015.

15. Hoog de G.S., Guarro J., Gene J., Figueras M.J. Atlas of clinical fungi. Electronic Version 3.1 – CBS: Reus, 2011.

16. Sherif R., Segal B.H. Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications. Curr Opin Pulm Med. – 2010. – Vol. 16. – P. 242-250.

17. The Aspergillus Website http://www.aspergillus.org.uk/

18. TREK Diagnostics Systems http://www.trekds.com/techinfo/default.asp

19. Walsh T.J., Anaissie E.J., Denning D.W., Herbrecht R, Kontoyiannis D.P., Marr K.A., Morrison V.A., Segal B.H., Steinbach W.J., Stevens D.A., van Burik J.A., Wingard J.R., Patterson T.F. Treatment of aspergillosis: clinical practice guidelines of the infectious Diseases Society of America – Clin Infect Dis. – 2008. – Vol. 46(3). – P. 327-360.

For citation

Kulko A.B., Fedorova N.I. Comparative in vitro activity of antimycotics against the causative agents of bronchopulmonary aspergillosis. Bulletin of Pirogov National Medical & Surgical Center. 2018;13(4):75-79. (In Russ.) https://doi.org/10.25881/BPNMSC.2018.49.83.014